Pazopanib hydrochloride is a multi-targeted receptor tyrosine kinase inhibitor used therapeutically for the treatment of advanced or metastatic renal cell carcinoma and soft tissue sarcomas. This category… Read more



Pazopanib hydrochloride is a multi-targeted receptor tyrosine kinase inhibitor used therapeutically for the treatment of advanced or metastatic renal cell carcinoma and soft tissue sarcomas. This category contains high-quality reference standards for the active pharmaceutical ingredient, alongside a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities. Laboratories utilize these compounds, including specific degradation products and stable isotope-labelled standards, for rigorous impurity profiling, method validation, and ongoing quality control of pharmaceutical formulations. Accessing these well-characterized reference materials is essential for ensuring accurate analytical testing and complying with regulatory standards throughout the drug development and manufacturing lifecycle.